Orion Office Reit

Ares Commercial

Ellington Residential Mortgage

Apple Hospitality

American Healthcare REIT

SITE Centers

Ready Capital

Wheeler REIT

AG Mortgage Investment Trust

Granite Point Mortgage

United States

SYDNEY, AUSTRALIA, Nov. 08, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a clinical-stage biotechnology company targeting cancer and autoimmune diseases, today announced positive data from its Phase I study of IMP761, its first-in-class LAG-3 agonist antibody, from a late-breaking abstract at ACR Convergence 2026 in Orlando, Florida. ACR Convergence is the annual scientific meeting of the American College of Rheumatology.

IMP761 Late-Breaking Abstract at ACR Convergence 2026 Highlights Statistically Significant & Exposure-Dependent Inhibition of T-Cell-Driven Immune Responses

On November 4, Wall Street closed higher after Democrats won Congress, and data center stocks fell sharply. The next day, IREN (NASDAQ:IREN) delayed its goal of more than $4 billion in operating annual recurring revenue (ARR).

Is America's AI Data Center Boom About to Hit a Brick Wall?

NNN REIT NYSE: NNN reported higher third-quarter earnings and maintained its full-year outlook, while executives said they are seeking higher acquisition yields after changes in capital markets prompted the company to reprice potential deals.

What NNN REIT (NNN) Said on Its Q3 Earnings Call

Two monthly-paying REITs look nearly identical on paper, yet one retiree is betting her income on swapping a giant for a smaller rival. What does she gain, what does she give up, and does her paycheck survive?

A 70-Year-Old Swapped O for ADC in a $1.03 Million Income Portfolio. Here’s What Happened to Her $5,650 Monthly Paycheck

TPG RE Finance originated $2.3 billion of loans over roughly 12 months. Non-mark-to-market liabilities reached 85% following a $1 billion debt issuance.

TPG RE Finance: 3 Key Takeaways for Long-Term Investors

NexPoint Real Estate Finance NYSE: NREF reported a third-quarter net loss of $0.65 per diluted share as unrealized losses on investments weighed on book value, while earnings and cash available for distribution rose from a year earlier.

NexPoint Real Estate Finance Q3 Earnings Call Highlights

100% (6 of 6) of dermatomyositis patients maintained immunomodulator-free, moderate-to-major TIS responses through one year, with most patients also free of steroids

Cabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable Benefit-Risk Profile Across Autoimmune Diseases

Smartstop Self Storage REIT NYSE: SMA raised its full-year 2026 outlook after reporting higher third-quarter same-store revenue and lower operating expenses, as the company used pricing and reduced concessions to maintain occupancy.

Smartstop Self Storage REIT Q3 Earnings Call Highlights

BRUSSELS and CAMBRIDGE, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced further data characterizing the clinical profile of dapirolizumab pegol (DZP), an investigational biologic for people living with systemic lupus erythematosus (SLE). The data are being presented across five posters at ACR Convergence 2026, the annual meeting of the American College of Rheumatology, in Orlando, Florida, November 6-11.

ACR 2026: Dapirolizumab Pegol Associated with Greater Treatment Response Rates Versus Placebo in SLE Using Novel Treatment Response Measure

Johnson and Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancerPR NewswireNEW BRUNSW

Johnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancer

LOS ANGELES, Nov. 9, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Millrose Properties, Inc. ("Millrose" or "the Company") (NYSE: MRP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MRP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

MRP Investors Have Opportunity to Lead Millrose Properties, Inc. Securities Fraud Lawsuit with SBS Law

Six household income stocks pay yields above 5%, and most just raised guidance. Yet debt loads, tenant concentration, and negative equity hide beneath the payouts.

6 Dividend Stocks With Big Yields and Bigger Warning Signs

Postal Realty Trust NYSE: PSTL raised its 2026 earnings and acquisition guidance after a record quarter of property purchases, as executives said improved access to capital and rising rents helped drive growth.

Postal Realty Trust Q3 Earnings Call Highlights

GT Biopharma showcased new preclinical data in an oral presentation at SITC demonstrating an enhanced effect of combining GTB-5550, a B7-H3-targeted tri-specific NK cell engager (TriKE®), with a KRAS inhibitor (KRASi), which was shown to sensitize pancreatic tumor cells to NK cell cytotoxicity The new data show that the combination promotes NK cell infiltration to provide superior disease control in orthotopic xenograft models, and provides novel mechanistic insight into KRAS-dependent anti-tumor NK regulation to establish a strong preclinical rationale for combining KRASi with GTB-5550 in pancreatic ductal adenocarcinoma (PDAC) A Phase 1a/1b basket trial with GTB-5550 monotherapy is currently underway (NCT07541573), which includes a cohort for PDAC patients, and the Company is considering potential options for a future Phase 1b study to evaluate the combination of GTB-5550 and a KRAS inhibitor SAN FRANCISCO, CALIFORNIA, Nov. 09, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, today announced preclinical data presented at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting taking place from November 4-8, 2026 in Phoenix, AZ. “We continue to make progress enrolling patients into our ongoing Phase 1a/1b dose escalation basket trial with GTB-5550 in multiple tumor types”, said Michael Breen, Executive Chairman and Chief Executive Officer of GT Biopharma.

GT Biopharma Oral Presentation at the SITC 2026 Annual Meeting

Clinically meaningful improvement in disease activity among 8 of 9 evaluable patients, including rapid and marked reductions in proteinuria with complete renal responses

Velinotamig, a BCMAxCD3 T Cell Engager, Achieves Complete Renal Responses and Significantly Reduces Disease Activity in Systemic Lupus Erythematosus in Data Presented at ACR Convergence 2026

Simon Property Group NYSE: SPG raised its full-year 2026 real estate funds from operations guidance after reporting third-quarter growth in property income, leasing and retailer sales.

What Simon Property Group (SPG) Said on Its Q3 Earnings Call

Millrose authorized a $250 million share repurchase program. Non-Lennar investments reached 42% of total assets after funding DreamFinders.

Millrose: 3 Key Takeaways for Long-Term Investors

Brixmor raised its full-year 2026 earnings and same-property income guidance. New lease rates grew 43% during the third quarter.

Brixmor: 3 Key Takeaways for Long-Term Investors

New York, New York--(Newsfile Corp. - November 9, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Millrose Properties, Inc. ("Millrose" or the "Company") (NYSE: MRP) on behalf of investors that purchased or otherwise acquired Millrose securities between February 7, 2025 and October 2, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Millrose and have suffered losses, you may CLICK HERE to contact us.

Kaplan Fox Alerts Millrose Properties, Inc. (MRP) Investors to a Securities Fraud Lawsuit - Lead Plaintiff Deadline is December 8, 2026

A permitting fight could stall the buildings that every AI chip, cable, and cooling system needs. While chip stocks sank in a single month, one corner of the market barely flinched.

David Sacks Warns the AI Data Center Pipeline Could Dry Up. Here's What's at Stake

She walked away from a lifetime guarantee and bet on six dividend payers instead. The paycheck looks tempting on paper, but one question about her future at 80 or 95 could decide whether the gamble holds up.

A 61-Year-Old Turned Down a $725,000 Annuity and Bought Dividends Instead. Here’s What Happened to Her $3,700 Monthly Paycheck

Mortgage REIT yields north of 15% look like a retiree's dream, until one CEO admits his dividend may not survive. Three lenders promise monthly-bill relief, but only one has the earnings to back up its payout.

$60,000 Split Across These 3 Real Estate Lenders Pays $8,554 a Year in Dividends

A retiree dumps his safe bond funds to close a small income gap, and his paycheck climbs. But the swap quietly trades away the cushion that protects him when stocks fall, and a dividend cut is already on the way.

A 68-Year-Old Swapped His Bond Funds for DIVO and GPIX in a $1.1 Million Portfolio. Here’s What Happened to His $6,700 Monthly Paycheck

NEK7-directed molecular glue degrader inhibited NLRP3 inflammasome activation in human experimental systems and demonstrated anti-inflammatory activity in a rabbit model of gouty arthritis GEMINI-1, a Phase 2 study of MRT-8102 in patients with gout, is expected to initiate in Q4 2026, with initial data expected in H2 2027 Poster presentation on November 9, 2026, at 10:30 a.m. ET BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the presentation of preclinical data showing that MRT-8102, a NEK7-directed MGD, inhibited NLRP3 inflammasome activity in human experimental systems and reduced inflammation in a rabbit model of gouty arthritis, supporting the Company's planned Phase 2 study in patients with gout.

Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2026 on the Potential of MRT-8102 in Gout

Essex Property

W. P. Carey

EPR Properties

Agree Realty

Alexandria

Realty Income

STAG Industrial

Public Storage

Prologis

Essential Properties

Outstanding dividend history and a safe payout ratio

Best Dividend REITs

Top Scorers

The 10 most popular REITs by page views on alreits

Dividend Streak 20y

REITs that have been growing dividends for more than 10 years

Dividend Growth Streak 10y

Equity REITs that have been reporting bad results over the last few years and therefore are considered riskier for a beginner investor

Equity REITs to Avoid

REITs that have been reporting good results and are easier to understand for a beginner investor

REITs For Beginners

All Equity REITs

Top Equity REITs with 5-Year Earnings per Share Growth, Ranked by Discount to 52-Week High

Discount to 52-week High

REITs with the lowest Debt/Assets ratio and a positive 5-year CAGR Earnings per Share growth

Low Leverage

REITs that offer a higher starting yield without compromising growth and dividend safety - the sweet spot for income-focused investors

Sweet Spot

Nexus Industrial REIT

Chartwell Retirement Residences

Automotive Properties

Dream Office

PROREIT

Allied Properties

American Hotel Income Properties REIT LP

CAPREIT

Killam Apartment

Boardwalk REIT

Canada

The multibillion-dollar deal to sell one of Canada’s largest property portfolios was dealt another blow on Monday as proxy adviser Glass, Lewis & Co. urged H&R Real Estate Investment Trust HR-UN-T unitholders to oppose a planned sale.
Glass Lewis joined its c…

Advisory firm Glass Lewis joins ISS in recommending against H&R REIT takeover deal

Dream Industrial REIT (TSX:DIR) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga

Dream Industrial REIT Q3 2026 Earnings Call Transcript

Nexus Industrial REIT (TSE:NXR.UN) reported higher third-quarter operating income and per-unit cash flow as it renewed industrial leases at higher rents, while executives outlined plans to develop potential data infrastructure at properties in British Columbi…

Nexus Industrial REIT Q3 Earnings Call Highlights

This article first appeared on GuruFocus.
Release Date: November 05, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
- Same property NOI grew 3.8% excluding anchors, showing healthy org…

SmartCentres Real Estate Investment Trust (CWYUF) (Q3 2026) Earnings Call Highlights: Strong ..

Boardwalk REIT (TSX:BEI) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs.

Boardwalk REIT Q3 2026 Earnings Call Transcript

Choice Properties

Dream Industrial

Granite REIT

RioCan

SmartCentres

The 10 most popular Canadian REITs by page views on alreits

REITs that have been growing dividends for more than 5 years

Dividend Growth Streak 5y

All REITs

Daiwa House Logistics Trust

CapitaLand China Trust

Frasers Logistics & Commercial Trust

Manulife US Real Estate Investment Trust

Ascott Residence Trust

Starhill Global Real Estate Investment Trust

Suntec Real Estate Investment Trust

Prime US REIT

Mapletree Pan Asia Commercial Trust

Ascendas Real Estate Investment Trust

Singapore

Parkway Life Real Estate Investment Trust

Keppel DC REIT

Mapletree Logistics Trust

CapitaLand Integrated Commercial Trust

Frasers Centrepoint Trust

Mapletree Industrial Trust

Keppel REIT

The 5 most popular REITs by page views on alreits

AEW UK REIT plc

Custodian REIT Plc

Tritax Big Box REIT plc

Land Securities Group plc

Grainger plc

Town Centre Securities PLC

Big Yellow Group Plc

SEGRO Plc

Safestore Holdings plc

British Land Company Plc

United Kingdom

LONDON, November 04, 2026--(BUSINESS WIRE)-- 
FORM 8.3 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY 
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 
Rule 8.3 of the Takeover Code (the "Code") 
1. KEY INFORMATION 
2. POSITI…

SMARTER REIT INVESTING STARTS HERE

United States

Performance Heatmap

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

Canada

Performance Heatmap

@-webkit-keyframes mui-auto-fill{from{display:block;}}@keyframes mui-auto-fill{from{display:block;}}@-webkit-keyframes mui-auto-fill-cancel{from{display:block;}}@keyframes mui-auto-fill-cancel{from{display:block;}}Sectors

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

Singapore

Performance Heatmap

@-webkit-keyframes mui-auto-fill{from{display:block;}}@keyframes mui-auto-fill{from{display:block;}}@-webkit-keyframes mui-auto-fill-cancel{from{display:block;}}@keyframes mui-auto-fill-cancel{from{display:block;}}Sectors

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

United Kingdom

Performance Heatmap

@-webkit-keyframes mui-auto-fill{from{display:block;}}@keyframes mui-auto-fill{from{display:block;}}@-webkit-keyframes mui-auto-fill-cancel{from{display:block;}}@keyframes mui-auto-fill-cancel{from{display:block;}}Sectors

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

France

Performance Heatmap

@-webkit-keyframes mui-auto-fill{from{display:block;}}@keyframes mui-auto-fill{from{display:block;}}@-webkit-keyframes mui-auto-fill-cancel{from{display:block;}}@keyframes mui-auto-fill-cancel{from{display:block;}}Sectors

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

India

Performance Heatmap

@-webkit-keyframes mui-auto-fill{from{display:block;}}@keyframes mui-auto-fill{from{display:block;}}@-webkit-keyframes mui-auto-fill-cancel{from{display:block;}}@keyframes mui-auto-fill-cancel{from{display:block;}}Sectors

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

South Africa

Performance Heatmap

@-webkit-keyframes mui-auto-fill{from{display:block;}}@keyframes mui-auto-fill{from{display:block;}}@-webkit-keyframes mui-auto-fill-cancel{from{display:block;}}@keyframes mui-auto-fill-cancel{from{display:block;}}Sectors

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

The income that investors can access by investing in REITs is a powerful wealth-building tool, but only if the REITs can sustain and preferably grow their dividends over time.

SMARTER REIT INVESTING
STARTS HERE

Sectors

Sectors

Sectors

Sectors

Sectors

Sectors